SAB awarded $60M more in government funding for COVID-19 therapeutic
The federal government has awarded additional funding of $60.5 million to Sioux Falls-based SAB Biotherapeutics as it advances its treatment for COVID-19.
SAB awarded $60M more in government funding for COVID-19 therapeutic
The federal government has awarded additional funding of $60.5 million to Sioux Falls-based SAB Biotherapeutics as it advances its treatment for COVID-19.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
